Rankings
▼
Calendar
VRDN Q1 2016 Earnings — Viridian Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
VRDN
Viridian Therapeutics, Inc.
$2B
Q1 2016 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$818,000
Gross Profit
$189,000
23.1% margin
Operating Income
-$3M
-334.4% margin
Net Income
-$3M
-337.2% margin
EPS (Diluted)
$-3.85
Cash Flow
Operating Cash Flow
-$2M
Free Cash Flow
-$2M
Stock-Based Comp.
$713,000
Balance Sheet
Total Assets
$11M
Total Liabilities
$2M
Stockholders' Equity
$8M
Cash & Equivalents
$9M
← FY 2016
All Quarters
Q2 2016 →
